76008-73-6 Usage
Description
ETHYL 5-BROMO-2-CHLOROBENZOATE is an organic compound characterized by its white to light yellow crystal powder appearance. It is a derivative of benzoic acid with a bromine atom at the 5th position and a chlorine atom at the 2nd position, attached to an ethyl ester group. This chemical structure endows it with specific properties that make it suitable for various applications in different industries.
Uses
Used in Pharmaceutical Industry:
ETHYL 5-BROMO-2-CHLOROBENZOATE is used as an intermediate compound for the synthesis of ethyl 6-bromo-3-chloro-3′-methylbiphenyl-2-carboxylate, which can be further utilized in the development of pharmaceutical products. Its unique chemical structure allows it to serve as a building block for the creation of new drugs with potential therapeutic applications.
Used in Chemical Synthesis:
In the field of chemical synthesis, ETHYL 5-BROMO-2-CHLOROBENZOATE is used as a key reactant in the production of various organic compounds. Its bromine and chlorine atoms can participate in a range of chemical reactions, such as substitution, addition, and elimination, enabling the synthesis of a wide array of molecules with diverse properties and applications.
Used in Research and Development:
Due to its unique chemical structure, ETHYL 5-BROMO-2-CHLOROBENZOATE is also employed in research and development laboratories. It can be used as a model compound to study various chemical reactions and mechanisms, as well as to test new synthetic methods and techniques. This helps researchers gain a better understanding of the underlying principles of organic chemistry and develop more efficient and environmentally friendly synthetic processes.
Check Digit Verification of cas no
The CAS Registry Mumber 76008-73-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,0,0 and 8 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 76008-73:
(7*7)+(6*6)+(5*0)+(4*0)+(3*8)+(2*7)+(1*3)=126
126 % 10 = 6
So 76008-73-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H8BrClO2/c1-2-13-9(12)7-5-6(10)3-4-8(7)11/h3-5H,2H2,1H3
76008-73-6Relevant articles and documents
Diamine as well as preparation method and application thereof (by machine translation)
-
Paragraph 0042-0043; 0045, (2020/12/31)
The structural formula of the diamine is shown as a formula (I). The invention also discloses a preparation method of the diamine, which comprises the following steps: 2 - chlorine -5 - bromobenzoate and magnesium metal; a metallization reaction occurs un
Design, synthesis, insecticidal activity and 3D-QSR study for novel trifluoromethyl pyridine derivatives containing an 1,3,4-oxadiazole moiety
Xu,Wang,Luo,Yu,Guo,Fu,Zhao,Wu
, p. 6306 - 6314 (2018/02/19)
A series of trifluoromethyl pyridine derivatives containing 1,3,4-oxadiazole moiety was designed, synthesized and bio-assayed for their insecticidal activity. The result of bio-assays indicated the synthesized compounds exhibited good insecticidal activity against Mythimna separata and Plutella xylostella, most of the title compounds show 100% insecticidal activity at 500 mg L-1 and >80% activity at 250 mg L-1 against the two pests. Compounds E18 and E27 showed LC50 values of 38.5 and 30.8 mg L-1 against Mythimna separata, respectively, which were close to that of avermectin (29.6 mg L-1); compounds E5, E6, E9, E10, E15, E25, E26, and E27 showed 100% activity at 250 mg L-1, which were better than chlorpyrifos (87%). CoMFA and CoMSIA models with good predictability were proposed, which revealed the electron-withdrawing groups with an appropriate bulk at 2- and 4-positions of benzene ring could enhance insecticidal activity.
4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
-
Paragraph 0565-0568; 0577, (2014/03/21)
The invention relates to 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalene derivatives of general formula (I) which are inhibitors of phosphodiesterase 2 and/or 10, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.